The first monoclonal antibody for cancer

    The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.

    Rituxan is approved for certain cases of B-cell lymphoma...a malignancy of the antibody-producing B-cells.

    Rituxan binds to these malignant cells...allowing the immune system to recognize and eliminate them.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote